At OU Health Stephenson Cancer Center, its patient navigation program helps patients on tribal lands get direct access to cancer specialists. bit.ly/44lCGTw

Adagrasib + pembrolizumab shows promise in PD-L1–positive KRAS G12C NSCLC. @LealTicianal: “Winning means good efficacy, but also good tolerability.” bit.ly/440WzjU

A new AI-developed IPF therapy may go beyond slowing the disease—it could improve lung function. “There is potential for a drug which can actually improve the lung function as compared to current therapy," said Vishal Deepak, MD. #AIinHealthcare bit.ly/4kfIX9k

A new test may help clarify one of the most pressing treatment questions in #lungcancer: who actually needs chemotherapy? Findings from the INSIGHT study presented at #ASCO25 show potential in this area. bit.ly/3TrEGoj

Wanna write killer intros? Take a tip from the #WWE's Paul Heyman: “Here is who I am and here is what I do.” It works—on the mic and on the page. Paul Heyman bit.ly/43swIRy #WritingTips #PaulHeyman #ContentWriting

"This conference goes beyond a typical oncology meeting … It exists to shift the narrative from one of persistent disparity to one of innovation, resilience, and community-led progress.” – Dr. Wade Swenson Read more: bit.ly/4nABODo #OncologyCare #CancerEquity

Crafting every sentence is like a movie director framing a shot. Here are three simple rules for doing so. #WritingTips #AmWriting bit.ly/409Y0Kt

Long-acting injectable PrEP could reshape HIV prevention, but only if it gets into the right hands. Results from a phase 4 trial show the potential in this area. bit.ly/4kvAJKh

You’re not writing for teachers anymore. You’re writing for clients. Larry McEnerney explains how to make that mindset shift—and why it matters. Watch the 4-min video: bit.ly/43AAPd6

“If we do not put some of these proposed solutions in place, there will absolutely be more oncology drug shortages in the future.” — Dr. Julie Gralow Julie Gralow ASCO proposes new solutions to prevent the next #DrugShortage: bit.ly/3GC6QdA #CancerCare #Oncology

Two TKIs—elenestinib and bezuclastinib—are showing statistically significant improvements in symptom reduction for systemic mastocytosis in large-scale trials. Full article: bit.ly/3GC6vHR #Oncology #SystemicMastocytosis #ClinicalTrials #AaronTallent

“#SystemicMastocytosis is a disease where the #MastCells, which are part of the normal immune system, increase.” Dr. Daniel DeAngelo, with Dana-Farber , explains systemic mastocytosis and what patients need to know about advanced vs. indolent forms. bit.ly/4mlNl80

NIH will no longer fund medical research using animal models exclusively, and many cancer researchers are raising questions. bit.ly/45A7zp0

With tens of thousands of news releases issued globally every day, how do you make sure yours stands out? First, don’t just write to inform, write to be quoted. bit.ly/3JckFjL

When I saw Geezer Butler move up and down the neck of his bass with ease, I felt that same sense of inadequacy most writers feel when reading Tom Wolfe or Maya Angelou. Here is how learning an instrument can make you a better writer. bit.ly/4lAT216

“It is alarming, and red flags do go up” — Ted Okon on Medicare’s new prior authorization pilot. Cancer care isn’t on the list yet. Here’s why oncologists are still watching closely: bit.ly/45epeme #MedicarePolicy

“We’ve got to do a better job of looking at dosing for patients…” Dr. R. Donald Harvey. ASCO has issued new principles that could help guide cancer drug trials & treatment. Here’s why this could mark a paradigm shift: bit.ly/45shGLu #ASCO

Listicles aren’t going anywhere. The key is making them worth scrolling. Here’s how: bit.ly/466AQXB

“Oncology ranks as the most in-demand medical specialty…” ∿ Jeff Decker, AMN Healthcare. Starting salaries for oncologists are climbing fast, here’s why: bit.ly/45qT1Iu #Oncology

Vince Lombardi’s name is on more than the #SuperBowl trophy. Georgetown’s cancer center also honors the NFL legend, who died there in 1970. This is just one story of how major U.S. cancer centers got their names. Full piece:bit.ly/3VuGldy